Finance

Lists
CHD:NYSE
Church & Dwight Co Inc
$102.93
-0.69%
(-0.71) 1D
Aug 6, 3:09:25 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHD...
Open
$104.00
High
$104.31
Low
$102.26
Mkt. cap
24.42B
Avg. vol.
1.89M
Volume
818.84K
Dividend
1.19%
Quarterly dividend
$0.31
Ex-dividend date
Aug 14, 2026
P/E ratio
33.12
52-wk high
$106.04
52-wk low
$81.33
EPS
$3.11
Beta
0.47
Shares outstanding
237.20M
No. of employees
6K
Open
$104.00
High
$104.31
Low
$102.26
Mkt. cap
24.42B
Avg. vol.
1.89M
Volume
818.84K
Dividend
1.19%
Quarterly dividend
$0.31
Ex-dividend date
Aug 14, 2026
P/E ratio
33.12
52-wk high
$106.04
52-wk low
$81.33
EPS
$3.11
Beta
0.47
Shares outstanding
237.20M
No. of employees
6K
News stories
From sources across the web
Profile
Church & Dwight Co., Inc. is an American consumer packaged goods company headquartered in Ewing Township, New Jersey. It manufactures and markets household, personal-care and specialty products in the United States and internationally. The company is best known for Arm & Hammer, whose baking soda and related products trace their origins to a business established by John Dwight and Austin Church in 1846. As of 2026, other major brands include Trojan, OxiClean, Nair, First Response, Orajel, Waterpik, Batiste, TheraBreath, Hero Cosmetics and Touchland. Church & Dwight operates through three business segments: Consumer Domestic, Consumer International and Specialty Products. Its consumer businesses sell laundry, cleaning, oral-care, hair-care, skin-care and reproductive-health products, while its specialty-products division supplies sodium bicarbonate and related materials for industrial, agricultural, medical and food applications. The company is listed on the New York Stock Exchange and is a component of the S&P 500. Wikipedia
About Church & Dwight Co Inc
CEOMatthew Farrell
Employees5.55K
Founded1846
HeadquartersEwing Township, New Jersey, New Jersey, United States
SectorHousehold goods
Websitechurchdwight.com
Analyst ratings
Based on 13 analysts giving stock ratings to CHD in the past 3 months
Buy
Buy
7
Hold
5
Sell
1
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for CHD in the last 3 months.
Highest
Current $102.93
$115.00 (+11.73%)
Average
$106.82 (+3.78%)
Lowest
$86.00 (-16.45%)
Analyst
Recommendation
Action
Price target
Projected
Date
Christopher Carey
Wells Fargo
Buy
Maintained
$110.00
+6.9%
08/03/2026
Lauren Lieberman
Barclays
Sell
Maintained
$86.00
-16.4%
08/04/2026
Anna Lizzul
Bank of America Securities
Buy
Reiterated
$115.00
+11.7%
08/03/2026
Stephen Powers
Deutsche Bank
Buy
Reiterated
$112.00
+8.8%
08/03/2026
Dara Mohsenian
Morgan Stanley
Hold
Reiterated
$112.00
+8.8%
08/03/2026
Peter Grom
UBS
Hold
Maintained
$107.00
+4%
08/03/2026
Nik Modi
RBC Capital
Buy
Reiterated
$115.00
+11.7%
08/03/2026
Filippo Falorni
Citi
Hold
Maintained
$105.00
+2%
08/03/2026
Robert Moskow
TD Cowen
Hold
Reiterated
$97.00
-5.8%
08/03/2026
Jon Andersen
William Blair
Buy
Maintained
-
-
07/31/2026
Andrea Faria Teixeira
J.P. Morgan
Hold
Maintained
$105.00
+2%
07/16/2026
Taylor Conrad
Argus Research
Buy
Maintained
-
-
06/08/2026
Bonnie Herzog
Goldman Sachs
Buy
Maintained
$111.00
+7.8%
05/29/2026
Javier Escalante
Evercore ISI
Hold
Maintained
$105.00
+2%
05/04/2026
Rupesh Parikh
Oppenheimer
Buy
Maintained
$115.00
+11.7%
02/23/2026
Edward Lewis
Rothschild & Co Redburn
Hold
Upgraded
$91.00
-11.6%
02/13/2026
Last report
Jul 31, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.89 / $0.90
-0.95%miss
Revenue / Est. (USD)
1.53B / 1.51B
+1.38%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.59B
1.64B
1.47B
1.53B
Cost of goods sold
871.20M
895.80M
787.90M
836.10M
Cost of revenue
871.20M
895.80M
787.90M
836.10M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
459.80M
443.30M
384.10M
417.50M
Operating expense
459.80M
443.30M
384.10M
417.50M
Total operating expenses
1.33B
1.34B
1.17B
1.25B
Operating income
254.60M
305.10M
297.30M
276.40M
Other non operating income
300.00K
1.80M
800.00K
-400.00K
EBT including unusual items
236.20M
188.10M
272.60M
255.90M
EBT excluding unusual items
236.20M
285.70M
278.90M
255.90M
Income tax expense
54.00M
44.60M
56.30M
53.10M
Effective tax rate
22.86%
23.71%
20.65%
20.75%
Other operating expenses
-
-
-
-
Net income
182.20M
143.50M
216.30M
202.80M
Net profit margin
11.49%
8.73%
14.72%
13.25%
Earnings per share
0.81
0.86
0.95
0.89
Interest and investment income
2.90M
2.10M
2.50M
1.40M
Interest expense
-23.80M
-24.60M
-24.00M
-24.20M
Net interest expenses
-20.90M
-22.50M
-21.50M
-22.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
310.70M
362.50M
353.70M
334.20M
Gain or loss from assets sale
-
58.50M
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps